MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 179 filers reported holding MIRATI THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,458 | +54.1% | 56,433 | +27.8% | 0.00% | +100.0% |
| Q2 2023 | $1,595 | +35.1% | 44,163 | +38.9% | 0.00% | 0.0% |
| Q1 2023 | $1,181 | -24.4% | 31,788 | -7.8% | 0.00% | -50.0% |
| Q4 2022 | $1,562 | -98.0% | 34,488 | +3481.3% | 0.00% | – |
| Q1 2022 | $79,000 | -46.6% | 963 | +8.2% | 0.00% | – |
| Q3 2021 | $148,000 | +3.5% | 890 | 0.0% | 0.00% | – |
| Q2 2021 | $143,000 | -50.5% | 890 | -47.4% | 0.00% | -100.0% |
| Q1 2021 | $289,000 | -83.5% | 1,692 | -89.0% | 0.00% | -66.7% |
| Q2 2020 | $1,749,000 | +336.2% | 15,322 | +193.3% | 0.00% | +200.0% |
| Q1 2020 | $401,000 | -71.4% | 5,224 | -51.9% | 0.00% | -66.7% |
| Q4 2019 | $1,400,000 | +326.8% | 10,866 | +157.8% | 0.00% | +200.0% |
| Q3 2019 | $328,000 | -86.8% | 4,215 | -82.5% | 0.00% | -85.7% |
| Q2 2019 | $2,479,000 | +151.9% | 24,075 | +79.2% | 0.01% | +133.3% |
| Q1 2019 | $984,000 | +337.3% | 13,435 | +152.8% | 0.00% | +200.0% |
| Q4 2018 | $225,000 | +359.2% | 5,314 | +231.7% | 0.00% | -50.0% |
| Q1 2018 | $49,000 | -94.6% | 1,602 | -97.9% | 0.00% | -94.6% |
| Q3 2017 | $911,000 | +91000.0% | 77,903 | +24018.6% | 0.04% | – |
| Q2 2017 | $1,000 | -66.7% | 323 | -44.3% | 0.00% | – |
| Q3 2016 | $3,000 | – | 580 | +716.9% | 0.00% | – |
| Q2 2016 | $0 | – | 71 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |